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VesicleThe ubiquitous bacterial pathogen, Staphylococcus aureus, expresses a large arsenal of virulence factors essential
for pathogenesis. The phenol-soluble modulins (PSMs) are a family of cytolytic peptide toxins which have mul-
tiple roles in staphylococcal virulence. To gain an insight into which speciﬁc factors are important in PSM-
mediated cell membrane disruption, the lytic activity of individual PSM peptides against phospholipid vesicles
and T cells was investigated. Vesicles were most susceptible to lysis by the PSMα subclass of peptides (α1–3 in
particular), when containing between 10 and 30mol% cholesterol, which for these vesicles is the mixed solid or-
dered (so)–liquid ordered (lo) phase. Our results show that the PSMβ class of peptides has little effect on vesicles
at concentrations comparable to that of the PSMα class and exhibited no cytotoxicity. Furthermore, within the
PSMα class, differences emerged with PSMα4 showing decreased vesicle and cytotoxic activity in comparison
to its counterparts, in contrast to previous studies. In order to understand this, peptideswere studiedusinghelical
wheel projections and circular dichroismmeasurements. The degree of amphipathicity, alpha-helicity and prop-
erties such as charge and hydrophobicity were calculated, allowing a structure–function relationship to be in-
ferred. The degree of alpha-helicity of the peptides was the single most important property of the seven
peptides studied in predicting their lytic activity. These results help to redeﬁne this class of peptide toxins and
also highlight certain membrane parameters required for efﬁcient lysis.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Staphylococcus aureus is an extremely versatile opportunistic
pathogen, capable of causing a wide range of human and animal dis-
eases [1,2]. This bacterium has a huge arsenal of virulence factors and
has demonstrated high levels ofmulti-drug resistance. This has resulted
in S. aureus becoming one of the most prominent causes of nosocomial
infection [3,4], with previous studies suggesting that S. aureus contrib-
utes to a higher mortality than HIV/AIDS in the US [5]. S. aureus
infections also cause a massive economic burden, resulting in approxi-
mately US$570 million in additional hospital costs in the European
Union [6]. Historically, methicillin-resistant S. aureus (MRSA) strains
were restricted to the hospital and as such labeled health care-
associated (HA-) MRSA, generally infecting immune-compromised pa-
tients. New MRSA strains have emerged over the last few decades that
are able to infect healthy people; these community-associated (CA-)
MRSA strains [7], have in their arsenal, both antibiotic resistance and
also enhanced virulence and ﬁtness [8].s).The rationale for this study has arisen from previous work whereby
phospholipid vesicles have been used as reporters for the presence of
bacterial virulence factors, with the ultimate aim of developing an inte-
grated sensor wound dressing [9,10]. Self-quenched ﬂuorescein encap-
sulated within vesicles is released on contact with bilayer active toxins.
Extensive work has been carried out using genetically engineered
S. aureus strains to understand the interaction between cytolytic secreted
components from this bacteria and the developed vesicle system [11].
Genomic and proteomic analysis of the toxins secreted by various
CA-MRSA strains identiﬁed a class of peptideswhich are highly cytotox-
ic to host neutrophils [12]. These phenol-soluble modulins (PSMs) are
generally classiﬁed as small, surfactant-like, alpha-helical peptides.
They can be categorized into two groups; the alpha class consisting of
four peptides of ~20 amino acids and the beta group comprising two
longer ~40 amino acid peptides (Table 2). As well as being cytotoxic
[12,13] these peptides are important in bioﬁlm formation [14], exhibit
antimicrobial properties [15] and have strong pro-inﬂammatory prop-
erties [16]. Interestingly, recent work has established the role of PSMα
peptides in mediating phagosomal escape of both professional and
non-professional phagocytes in clinically important S. aureus strains
[17]. This survival within speciﬁc cells is an efﬁcientmethod of immune
evasion and, when in migrating immune cells, dissemination [17]. Im-
portantly, deletion of the psmα operon leads to attenuation in a
Table 1
Vesicle types and composition.
Vesicle Composition (% molar ratio) mol% cholesterol in
ﬂuid lipid domain
73% DPPC; 2% DPPE; 0% cholesterol; 25% TCDA 0
63% DPPC; 2% DPPE; 10% cholesterol; 25% TCDA 13.3%
53% DPPC; 2% DPPE; 20% cholesterol; 25% TCDA 26.7%
43% DPPC; 2% DPPE; 30% cholesterol; 25% TCDA 40%
33% DPPC; 2% DPPE; 40% cholesterol; 25% TCDA 53%
23% DPPC; 2% DPPE; 50% cholesterol; 25% TCDA 66.7%
Abbreviations: 1,2-dipalmitoyl-sn-glycero-phosphocholine, DPPC; 1,2-dipalmitoyl-sn-
glycero-phosphoethanolamine, DPPE; 10, 12-tricosadiynoic acid, TCDA.
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their central role in pathogenesis [12].
The PSMpeptides are inter-related and share similar physiochemical
and structural properties to the S. aureus delta toxin [12]. The mecha-
nism of action of delta toxin has been investigated using 1-palmitoyl-
2-oleoylphosphatidylcholine (POPC) containing vesicles with speciﬁc
ratios of cholesterol and sphingomyelin as a function of POPC [18]. The
mechanism ofmembrane lysis by delta toxin involves binding and accu-
mulation within liquid disordered lipid domains [18]. It is believed that
delta toxin functions through association of the hydrophobic face of
peptide molecules with the bilayer interior of cell membranes. Subse-
quent accumulation of the peptide in the membrane increases the
bending modulus and allows for the formation of membrane discs
which are bound by delta toxin to prevent interaction between the
aqueous environment and the bilayer hydrophobic core. Concurrently,
pores are generated in the membrane which leads to rapid osmotic de-
stabilization of the cell [19]. A recent study investigating PSM interac-
tion with POPC vesicles, demonstrated that all PSM peptides lyse such
vesicles [20], importantly even those that show no cytolytic activities
to eukaryotic cells, such as the PSMβ1 and β2 peptides and
the PSMα4 [12]. It was also reported that all PSM peptides exhibited
quite similar alpha-helical properties demonstrated by circular
dichroism [12].
In the study presented here, PSM–lipidmembrane interactionswere
studied, using phospholipid vesicles containing varying concentrations
of cholesterol, encapsulating a self-quenched ﬂuorescent dye, carboxy-
ﬂuorescein (CF). The effective concentration of peptide required to
lyse 50% of vesicles, EC50, was measured by quantifying ﬂuorescence
change as a function of PSM concentration using a dose response
curveﬁtting to theHill equation. Finally, experiments designed to inves-
tigate the structural properties of the PSMswere undertaken. Here heli-
cal wheel projections were generated to gain an understanding of
differences in structural properties between these groups. While all
PSMs displayed amphipathicity, which is vital for membrane lysis, we
hypothesize that differences in charge, hydrophobicity andmost impor-
tantly alpha-helical secondary structure explains the lytic differences
between these related peptide toxins.
2. Materials and methods
2.1. Phospholipid vesicle formulation
The vesicles used in this study all utilize a photo-polymerized fatty
acid, 10, 12-tricosadiynoic acid (TCDA) component, which is believed
to create speciﬁc phase domains separate from the phospholipids.
The vesicles can be thought of as hollow spheres consisting of a ‘hard’
shell of TCDA with pores containing 1, 2-dipalmitoyl-sn-glycero-
phosphocholine (DPPC), cholesterol and a small fraction of 1, 2-
dipalmitoyl-sn-glycero-phosphoethanolamine (DPPE) in a more ﬂuid
domain. Cholesterol concentration is expressed throughout as total
mol% cholesterol, including the TCDA component, whichwill underesti-
mate cholesterol concentration in the ﬂuid lipid phase. Table 1 gives es-
timates of cholesterol in the ﬂuid DPPC / DPPE phase.
Vesicles were formulated using 100 μmol dm−3 stocks of DPPC,
DPPE, TCDA, and cholesterol in chloroform. Different vesicle types
with differing cholesterol compositions were synthesized using molar
ratios shown in Table 1. Following solvent evaporation, lipid ﬁlms
were rehydrated using 5(6)-carboxyﬂuorescein (Sigma) buffer
(50 μmol dm−3), freeze thawed three times using liquid nitrogen and
extruded at 60 °C through a 100 nm membrane (Liposofast). Vesicles
were further puriﬁed through a NAP-25 column (GE Healthcare) kept
at 4 °C overnight and the incorporated TCDA was polymerized using a
UV-crosslinker (UVP CL1000) at an energy of 1600 μJ cm−2 with the
major component at 254 nm.
Vesicles remain stable in these conditions for a period of up 20 days
[21]. Size distribution and concentration of vesicle was measured viadynamic light scattering (Malvern) and nanosight tracking analysis
(Nanosight Ltd) respectively, producing a size distribution of 90–
110 nm and concentration of 1 × 108 particles μl−1. Phospholipids
and cholesterol were ordered from Avanti Polar Lipids.
2.2. Determining the lytic activity and EC50 of synthetic PSMs
The parameter for measuring the ﬂuorescence intensity of lysed
vesicles was set at excitation and emission wavelengths of 485–
520 nm respectively and a gain of 650 using a FLUOstar ﬂuorometer
(BMG labtech). 50 μL of vesicle solutionwas incubatedwith 150 μL of in-
dividual synthetic PSMs (95% purity, Severn Biosciences) dissolved in
PBS to a ﬁnal concentration ranging from 10 μmol dm−3 to
0.1 μmol dm−3 (PSMα1-4 and δ-toxin) and 50 μmol dm−3 to
0.1 μmol dm−3 (PSMβ1-2) for up to 1 h at 37 °C, with individual mea-
surements taken in 1 min intervals. Each experiment was performed
in triplicate, three times using different batches of vesicles in each ex-
periment. Both positive (0.1% triton X-100) and negative (Hepes buffer)
controls were used in ﬂuorescence normalization. The effective concen-
tration of speciﬁc synthetic peptides or bacterial supernatant required
to generate 50% of the maximum possible vesicle lysis, (EC50), within
an individual experiment was determined by observing the ﬂuores-
cence response of vesicles to each toxin concentration. Normalized ﬂuo-
rescence (NFl) values from 60 min were plotted against toxin
concentration for each toxin. Each data set was ﬁtted to the Hill Eq. (1):
NFl ¼ toxin½ 
n
EC50
n þ toxin½ n ð1Þ
where EC50 = concentration at half max response and n = stoichio-
metric factor. Fittingwas performedusingOrigin. The only ﬁt parameter
applied to the data was that the ﬁt origin must not pass below 0.
2.3. Assessing the lytic response of vesicles to bacterial supernatant
S. aureus strain LAC (USA 300, CA-MRSA) [22] was routinely stored
at−80 °C in 15% glycerol/broth stocks until required. This strain was
maintained in tryptic soy (TS) media (Fluka). A single colony was incu-
bated in 5ml of TS broth (TSB) incubated for 18 h at 37 °Cwith shaking
at 180 rpm. Bacterial supernatantswere harvested from1ml of 18h cul-
ture after centrifugation for 10min at 14,000 g using a bench top centri-
fuge. The ﬁltered supernatant was dilutedwith fresh TSB to gain a series
of supernatant concentrations ranging from 100% to 1%. Experiments
were done in triplicate, three times using the same protocol and param-
eters as above.
2.4. Cell toxicity assay
The immortalized T-cell line (T2 cells [23]) were grown in T75
tissue culture ﬂasks (Corning) containing RPMI 1640 cell culture
media (Gibco) containing 10% heat-inactivated fetal bovine serum,
1 μmol dm−3 of L-glutamine, 200 units mL−1 of penicillin and
0.1 mg mL−1 of streptomycin, at 37 °C in a humidiﬁed incubator with
3155M. Laabei et al. / Biochimica et Biophysica Acta 1838 (2014) 3153–31615% CO2 in air. Cells were routinely viewed microscopically and split
every 48–60 h. Cells were harvested by centrifugation at room temper-
ature for 5 min at 500 g, gently washed and resuspended in tissue-
culture grade phosphate buffered saline (PBS) (Invitrogen) to a ﬁnal
concentration of 1–1.5 × 106 cells mL−1. This procedure typically
yielded N 95% viability of cells, as determined by trypan blue exclusion
using 0.4% trypan blue solution (Sigma). Individual PSMs were diluted
to different concentrations in PBS and incubated at a 1:1 ratio with
cells for 12 min at 37 °C. The number of cells lysed was determined by
trypan blue exclusion and enumerated using a Fast-Read counting
chamber (Immune System LTD) and the percentage viability calculated.
All experiments were done in duplicate, three times and error repre-
sents the 95% conﬁdence interval.2.5. Circular dichroism measurement and helical wheel modeling
The structures of synthetic PSM peptides were analyzed by circular
dichroism (CD) using a Chirascan spectrometer (Applied Photophysics)
and a path length of 0.2 cm. Solutions of PSMpeptideswere prepared in
1 ml PBS at concentrations between 30 and 60 μmol dm−3. Due to the
hydrophobic nature of the PSMβ 1 and 2 peptides, they were dissolved
in 10 μL DMSO (ﬁnal concentration 0.05%) initially and then to the re-
quired concentration with PBS. This buffer was also used in subsequent
studieswith these respective peptides. PSMbeta peptideswere also dis-
solved in 50% triﬂuoroethanol (TFE) (Sigma) to induce secondary struc-
ture. The experiments with the PSMβ peptides in 50% TFE were
conducted using a 0.5 mm cuvette. Measurements were converted to
mean residual molar ellipticity (θ) and were performed in triplicate
and the resulting scans were averaged, smoothed, and the buffer signal
was subtracted. Helical wheel projections were constructed using heli-
cal wheel analysis software (http://rzlab.ucr.edu/) and the primary
amino acid sequence of the PSMs in Table 2.3. Results and discussion
3.1. Investigation of the lytic activity of PSMs
The initial experiments reported here were designed to understand
the concentration range required to lyse the 20 mol% cholesterol DPPC
vesicles, quantiﬁed in terms of the respective PSM EC50 values as
shown in Fig. 1 (A–D). TCDA was added to stabilize the vesicles, as
thismolecule polymerizeswithin themembrane followingUV exposure
[10]. Fig. 1 (A–C) illustrates the normalized ﬂuorescence (NFl) response
to the PSMs over a concentration range of 0.1–10 μmol dm−3 (or in the
case of the β peptides 0.1–50 μmol dm−3), following 60 min of incuba-
tion. The maximum ﬂuorescence value for the PSMα1, 2 and 3 peptides
and delta toxin was between 0.8 and 0.95 NFl units, which was
established with a toxin range of 2–4 μmol dm−3, whereas PSMα4 re-
quired 6 μmol dm−3 to achieve 0.7 NFl units. The PSMβ1 and β2 pep-
tides were much less active (Fig. 1C), with an order of magnitude
greater concentration (50 μmol dm−3) of peptide required to reach a
maximum normalized ﬂuorescence of 0.95 (PSMβ1) and 0.8 (PSMβ2).Table 2
Amino acid sequence of peptide toxins and respective hydropathicity and charge values.








Primary sequence of delta and PSMs toxins, all of which were N-formylated.Fig. 1D shows that PSMα2 and PSMα3 have the greatest lytic activity
to the vesicles, followed by PSMα1 and delta toxin. The PSMβ1-2 toxins
have an EC50 almost an order of magnitude lower than the PSMα1-3.
Furthermore a signiﬁcant increase between EC50 values of these
PSMα1–3 peptides and PSMα4 (p = 0.014) was observed. These re-
sults are in contrast with the work of Duong et al., where rapid lysis of
POPC vesicles after exposure to 0.5 and 1 μmol dm−3 PSMβ1, PSMβ2
and PSMα4 was observed [20]. Our results are consistent with the
PSM pattern in lytic activity observed with eukaryotic cells (Fig. 5),
with PSMα1–3 & delta toxin N PSMα4 N PSMβ1–2.
3.2. Effect of cholesterol variation on PSM mediated vesicle lysis
The effect of membrane cholesterol concentration on the activity of
the various peptide toxins are shown in Figs. 2 and 3. Fig. 2 shows the
peptide concentration–response curves and ﬁt from the Hill Eq. (1) for
each peptide and cholesterol concentrations between 0 and 50 mol%;
Fig. 3 is a histogram of the EC50 values (where able to be reasonably es-
timated) for obtained from theHill ﬁt of data in Fig. 2. Certain trends be-
come clear: The general peptide activity proﬁle seen for 20 mol%
cholesterol case discussed in Fig. 1 is seen for virtually all cholesterol
concentrations i.e. PSMα1–3 & δ toxin N PSMα4 N PSMβ1–2. Trends
in the effect of variations of lower concentrations of cholesterol are
less clear, but by viewing the EC50 values (Fig. 3) estimated from a
Hill ﬁt of data in Fig. 2, it can be seen that having some cholesterol in
the membrane (between 10 and 30 mol%) increases the lytic activity
of all the peptides except δ toxin,which is insensitive tomembrane cho-
lesterol concentration between 0 and 40% but totally inhibited at 50%
cholesterol.
The dose response curves for both the PSMβ peptides in Fig. 2 (F–G)
show that the lytic function of the peptide is effectively inhibited by
membrane cholesterol concentrations of 40 and 50 mol%. An EC50
value was not determined for the activity of the PSMβ1 and PSMβ2
against 40 and 50 mol% cholesterol, due to a low response and poor ﬁt
to the Hill equation.
Studies by other groups of PSM mediated POPC vesicle lysis showed
a reverse lytic pattern to that observed using the DPPC vesicles in this
study, with PSMα4 and PSMβ1 and β2 highlighted as the most efﬁcient
at vesicle lysis [20]. We hypothesize that the effect of cholesterol in
the membrane and the high phase transition temperature of vesicles
without, or with low concentrations of cholesterol mean that the DPPC
vesicles respond quite differently to POPC vesicles, which contain unsat-
urated fatty acid tails and much lower phase transition temperatures.
The variation in the response of vesicles to PSMswith change in cho-
lesterol concentration may have a biological context. As previously
demonstrated, PSMs are active against numerous cell types in numer-
ous organisms, which will have varying and dynamic bilayer composi-
tions. For example, neutrophils of adult rats have been demonstrated
to have a cholesterol to phospholipid ratio of 0.011 [24], while erythro-
cytes from adult humans give a ratio of 0.59 [25]. This variation in the
PSMs capacity to lyse membranes of varying cholesterol concentration
may indicate a mechanism employed by S. aureus to selectively lyse a






KLFGF (44) 0.570 −1
GKLFGF (44) 0.607 0
Fig. 1. Study into the effect of delta, PSM alpha and beta toxins against DPPC53 vesicles. Panels A), B) and C) show the response of DPPC (20 mol% cholesterol) vesicles to δ toxin, the
PSMα1–4 and the PSMβ1–2 toxins respectively. Fluorescence values were taken after 60 min of exposure of the vesicles to the indicated peptide concentration. Peptide concentrations
from 0.1 μmol dm−3 to 10 μmol dm−3 were used for delta toxin and the PSMα1–4 toxins. For the PSMβ1–2 a concentration rage from 0.1 μmol dm−3 to 50 μmol dm−3 was used.
D) EC50 values (effective concentration of toxins required to reach a ﬂuorescence value half that of the maximum), of each of the peptides tested against the vesicles. EC50 values were
determined through ﬁtting of the normalized ﬂuorescence vs toxin concentration data to a dose response curve.
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that PMNs from different mammals have different susceptibilities to
PSMs, with mouse neutrophils (BALB/c and C57/BL6) being more resis-
tant to PSMs than rabbit or human neutrophils [26]. S. aureusmay have
evolved to secrete small peptides which have preferences to cell types
based purely on membrane composition, adding to the hugely effective
arsenal of toxins in which this bacterium possess [27]. This preference
for membrane structure, dictated by cholesterol gains credibility con-
sidering that there are no known protein receptors for PSMs.
Cholesterol can impart liquid ordered like character to localized
areas of the bilayer by inﬂuencing chain packing behavior of lipids in
its immediate vicinity as previously demonstrated by Pokorny et al.,
with delta toxin partitioning primarily to the liquid-ordered phase of a
bilayer [28]. Measurements here were all made at 37 °C which makes
the vesicles quite sensitive to cholesterol composition: pure DPPC has
a phase transition temperature of 41 °C so the effect of adding choles-
terol takes the membrane from the solid ordered phase so at b7 mol%
cholesterol; mixed so–liquid ordered lo phases up to ca. 30mol% choles-
terol; and liquid ordered above 30 mol% cholesterol [29].
3.3. Lysis of vesicles by S. aureus supernatant
Bacterial supernatant is a mixture of proteins, peptides and small
molecules secreted by bacteria as they grow, as well as components ofgrowthmedia. Previouswork has identiﬁed PSMs as the primary secret-
ed S. aureus virulence factors that lyse DPPC vesicles [11]. The clinically
important S. aureus strain, LAC (USA300), secretes a cocktail of both
delta toxin and PSMs. Experimentswere carried out to study the lytic ef-
fect of dilutions of supernatant from this strain as a function of vesicle
cholesterol concentration (Fig. 4).
The attenuation of vesicle response at high (50 mol%) cholesterol
concentration is observed in a similar fashion to the pure PSMs
(Fig. 2). The undiluted LAC supernatant was highly lytic, the interesting
difference in response is at higher dilutions, where the response of the
vesicles is inversely proportional to membrane cholesterol concentra-
tion (see for example 6% LAC supernatant) not fully observed for most
of the pure toxins, wheremaximumﬂuorescence responsewas general-
ly seen in vesicles with between 10 and 30 mol% cholesterol. These re-
sults suggest that when PSMs are acting synergistically the rigidity in
membrane ﬂuidity imposed by cholesterol negatively affects PSM-
mediated permeabilization.3.4. Lysis of T-cell mediated by PSM peptides
The results from the study of vesicles with 20 mol% cholesterol
shown in Fig. 1 suggest three distinct levels of lytic activity depending
on the speciﬁc peptide. Experiments were carried out to see whether
Fig. 2. The effect of cholesterol variation on the lysis of vesicles by PSMs. Vesicles with differing concentrations of cholesterol, 0% to 50% were incubated with A) PSMα1, B) PSMα2,
C) PSMα3, D) PSMα4, E) δ toxin, in the concentration range of 0.1 to 10 μmol dm−3 and F) PSMβ1 and G) PSMβ2, in the concentration range of 0.1 to 50 μmol dm−3 for 1 h and ﬂuores-
cence values measured and normalized.
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(Fig. 5).
The range of concentrations used in the T cell experiments were
higher than those used in the vesicle studies due to poor or nominal kill-
ing seen over the 0.1–10 μmol dm−3 concentration range for themajor-
ity of toxins. The general pattern of lysis in terms of the most, and least,
lytic species of PSMs correlates well with the pattern seen for the vesi-
cles. As shown in Fig. 5, PSMα2 and PSMα3 show the highest levels of
cytotoxicity, closely followed by PSMα1. The EC50 for PSMα1 and
delta toxin are equivalent in the vesicle assay, but PSMα1 shows signif-
icantly greater killing in the T cell assay. PSMα4 is again seen to be less
lytic than delta toxin or the rest of the PSMαs. As with the vesicle assay,
the PSMβ class are signiﬁcantly less lytic than the PSMα class or delta
toxin, however the difference between PSMβ1 and PSMβ2 observed in
the vesicle assay is not seen in the cell toxicity assay as nokillingwas ob-
served despite the relatively high toxin concentrationsused. Overall, the
results generated in the vesicle-PSM studies are consistent with the ef-
fect of PSM on important immune cells. This pattern of cytotoxicity is
similar to that measured by other researchers on PMNs [12] and eryth-
rocytes, with the exception that PSMβ1 showed greater hemolyticactivity than β2 [13] which is the opposite of results obtained using
the DPPC vesicles (Fig. 1) and is not seen in the T cell assay (Fig. 5) or
PMN assay [12].
3.5. Secondary structure analysis
Studies of antimicrobial peptides (AMPs) suggest that there are two
functional requirements needed for active membrane destabilization: a
net positive charge to facilitate interaction with the negatively charged
phospholipid membrane; and the potential to form amphipathic struc-
tures which allow incorporation into the membrane [30,31]. Other pa-
rameters which can strengthen the incorporation of peptides into lipid
membranes include the overall hydrophobicity of the peptide, the
ratio of hydrophobic to charged residues (h:c) and the degree of struc-
turing [32–34]. In light of these parameters and using the hypothesis
that PSMs act in a similar fashion to AMPs and delta toxin, we investi-
gated these properties in an attempt to understand thedifferent lytic ac-
tivities of these peptides.
The delta and PSMα1–3 peptides consist of between 46 and 54% hy-
drophobic residues, which is consistent with the requirement for an
Fig. 3. EC50 values of PSMswhen incubatedwith phospholipid vesicles of different choles-
terol concentrations. EC50 values were determined from the dose response ﬁt of the nor-
malized ﬂuorescence vs concentration data. Where ﬂuorescence maxima did not reach
the required 0.5 normalized ﬂuorescence units value, they were excluded.
Fig. 5. PSMmediated lysis of T cells. T cells were incubatedwith increasing concentrations
of synthetic PSMs in the range of 15–100 μmol dm−3, and resulting T cell viability was
assessed. The PSMα1–3 shows the highest toxicity, giving the lowest T cell survival. The
PSMβ1–2 showed no toxicity against T cells whereas PSMα4 was only toxic at high con-
centrations. Delta (δ) toxin illustrated an intermediate level of toxicity.
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contained 70% hydrophobic residues, giving the highest hydropathicity
score using theKyte andDolittle algorithm,where a highhydropathicity
value indicates high hydrophobicity (Table 2) [35]. Previous studies
using AMPs observed that increased hydrophobicity lead to a decrease
in interaction with negatively charged membranes and under certain
conditions the more hydrophobic a peptide, the lower its membrane
lytic capability [30,36]. PSMα4 also has the highest hydrophobicity to
charge (h:c) ratio among the PSM peptides, which may further explain
its lower lytic capacity. Overall charge on the delta and PSMα1–4 was
positive (Table 2) with PSMα2 N PSMα1 = PSMα3 = PSMα4 N delta,
within the limits of charge typical for lytic peptides, as excessive charge
is potentially damaging towards lytic activity by preventing suitable
structuring [37]. The PSMβ1 peptide has an overall negative charge
whereas PSMβ2 displays a neutral charge, both peptides have a high
h:c ratio which may in part explain the low lytic phenotype.
Helical wheel projections of these peptides (Fig. 6) illustrate that like
delta toxin, all the PSMα peptides have a predicted helical structureFig. 4. Effect of cholesterol on vesicle lysis mediated by Staphylococcus aureus strain LAC
supernatant. Different dilutions of cell-free supernatant (0–100%) were incubated with
vesicles with varying cholesterol concentrations (0–50%).with a high degree of amphiphilicity, with PSMα3 showing the largest
hydrophobic moment (PSMα3 N delta N PSMα4 N PSMα2 N PSMα1,
ranging from 9.16 to 5.96) and PSMβ1 and β2 relatively lower (6.23
and 4.29, respectively). PSMα3 is the most toxic towards polymorpho-
nuclear leukocytes (PMNs) [12] and in this study, is most lytic to lipid
vesicles and T cells. It has been observed that ionic or salt bridges may
form when negatively charged residues are spaced 3 to 4 positions
from positively charged residues, which may promote helix formation
[38]. PSMα3 shows the largest number of charged residues (positive
and negative) on the hydrophilic phase of the predicted helix, indicating
the potential formation of helix stabilizing ionic bonds. This coupled
with the large hydrophobic moment for PSMα3 will likely increase
both peptide agglomeration in solution and partitioning of the peptide
into the lipid bilayer [39].
Circular dichroism spectroscopy analyses (Fig. 7A–B) illustrate those
PSM peptides that were highly lytic (PSMα1–3) displayed a higher de-
gree of alpha-helical secondary structure whereas PSMα4 and particu-
larly PSMβ1–2 show reduced helical characteristics (based on CD peak
intensity at 190 and 210 nm). Alpha-helicity is important in the ability
of small peptides to integrate within the lipid membrane and cause dis-
ruption as this type of structure allows for the formation of both hydro-
philic and hydrophobic faces [40–42]. The structuring is inﬂuenced by
both the overall hydrophobicity of the peptide, whichwill govern initial
interaction with the bilayer surface and subsequent interactions be-
tween individual residues on the hydrophobic face of the peptide and
the bilayer interior. It is worth noting that the PSMα1–3 peptides pos-
sess helix stabilizing alanine residues at position 5whereas PSMα4 con-
tains a helix destabilizing glycine in this position which may reﬂect the
observed difference in alpha-helicity.
Delta toxin exhibited a high degree of both amphipathicity and
alpha-helicity, with well-deﬁned hydrophobic and hydrophilic phases,
but had lower lytic and cytolytic activity than PSMα2–3 (Figs. 1D and
5). The lower lysis activity is intriguing and may be due to the low
hydropathicity value and a neutral charge affecting efﬁcient initial inter-
action and insertion within the membrane. Previous studies have dem-
onstrated that aliphatic residues decreasingly promote alpha-helix
stability in the order Leu N Ile N Ala N Val N in a lipid environment [43,
44]. The combined number of all aliphatic residues within each peptide
(discounting glycine), varies in the order 6 (PSMα3), 8 (PSMα2), 9
(PSMα1), 9 (delta toxin) and 12 (PSMα4). Of those residues PSMα3
has proportionately the highest leucine content while PSMα4 has the
Fig. 6. Helical wheel projections of delta toxin, PSMα1, α2, α3, α4, PSMβ1 and β2. Hydrophobicity is color coded from dark green (most hydrophobic) to yellow (zero hydrophobicity).
Hydrophilic amino acids are shaded from red (most hydrophilic) to yellow, charged residues are shown in light blue (reference; http://rzlab.ucr.edu/). The arrows indicate the directions of
the hydrophobic moments.
3159M. Laabei et al. / Biochimica et Biophysica Acta 1838 (2014) 3153–3161lowest. The number of aliphatic residues a peptide contains therefore
shows an approximate inverse correlation with EC50 values obtained
for each when challenging 20 mol% cholesterol vesicles Fig. 1D.It is important to note that delta and PSMα1–3 illustrated good
alpha-helical spectra in the absence of lipid membranes and alpha-
helical inducing solvents such as TFE. The PSMβ1–2 peptides, which
Fig. 7. Circular dichroism (CD) spectra of synthetic PSMs. A) CD spectra of PSMα1–4 and
delta toxin prepared in PBS. B) CD spectra of PSMβ1 peptide in 50% TFE (triﬂuoroethanol),
PSM β1 peptide in PBS buffer, PSMβ2 peptide in 50% TFE and PSMβ2 peptide in PBS buffer.
The peaks at 190 and 210 nm are indicative of alpha-helicity. The negative peaks at
202 nm andminimal negative peaks at 220 nm indicate random coil secondary structure.
3160 M. Laabei et al. / Biochimica et Biophysica Acta 1838 (2014) 3153–3161show the lowest lytic potential, are relatively unstructured in the ab-
sence of TFE. These peptides instead possess a random coil structure.
However, under our conditions, PSMβ1–2 exhibited increasing alpha-
helicity when dissolved in 50% TFE as shown in Fig. 7B. Previous results
have shown that all PSMpossess alpha-helicity, however these peptides
were dissolved in 50% TFE [12] which is known, and observed by us, to
induce alpha-helicity. Our results suggest that the ability to form alpha-
helical structure is extremely important in lysing cholesterol containing
lipid vesicles, as those PSM which have poor alpha-helical folding also
have poor lytic activity.
4. Conclusions
The lytic activity of PSM peptides from virulent strains of S. aureus
has been studied here. Physico-chemical properties of peptides affect
their ability to both penetrate and lyse phospholipid membranes. On
the basis of the results presented here, the degree of alpha-helicity is
the most important property for correct insertion and lysis of mem-
branes for PSM peptides.
The PSMβ1–2 peptides, which show the lowest lytic potential, are
relatively unstructured in the absence of TFE, instead possessing a ran-
dom coil structure which is not conducive to high lytic activity. Why
the PSMα4 or PSMβ1–2 peptides have lower alpha-helicity is not
completely understood as yet but maybe due to the presence of helix
breaking residues. Therefore, we suggest reﬁning this class of peptides,as not all of themembers have alpha-helicity, which is an important fac-
tor in membrane lysis.
The ability of these PSM to act synergistically with other toxins has
been recently reported and shown to be involved in S. aureus escape
from epithelial and endothelial phago-endosomes [45]. This study re-
ported the synergistic effect of delta toxin or PSMβ1–2 with the
sphingomyelinase β-toxin in disrupting the endosomal membrane
when these toxinswere overexpressed in non-virulent strains. Interest-
ingly, no synergistic effectwas observedwith the PSMα peptides,which
are more related to delta toxin than the PSMβ peptides and recently
shown to be important in phagosomal escape [17]. Currently, it is un-
known if PSMs can act synergistically with each other, andwhat molec-
ular interaction may dictate such effects. Experiments designed to
investigate how PSMs acting in synergy affect different phospholipid
vesiclemembranes and how they inﬂuence the structure of one another
are ongoing and will hopefully shed light onto how these interesting
peptides act during pathogenesis.
Recentwork has shown that serum lipoproteins inactive the lytic ac-
tivity of PSMs [46]. This result, in partnership with studies showing the
importance of PSMα peptides in the lysis of intracellular compartments,
suggests that themainmode of action of PSMs is lysis of thephagosomal
membrane. Interestingly, cholesterol is a major component of lipid
rafts which is required for initiating signals for phagocytosis [47]. Cho-
lesterol containing lipid rafts are also evident in the phagosomal mem-
brane [47]. Our results indicate that the expression of delta toxin,
PSMα1, -2 or -3 will lead to the lysis of cholesterol-containing vesicles
and that the progression from a liquid-disordered to liquid ordered
state following the addition of cholesterol to the membrane results in
decreased lytic activity. Differences in cholesterol concentration in
phagosomes from different cell types/species may impact of PSM-
mediated phagosome escape and subsequent survival of S. aureus.
Finally, it appears that there is a good correlationbetween the results
obtained from the vesicle assay (Fig. 1) and the cytotoxicity measure-
ments of PSMagainst T cells (Fig. 5),which suggests that using lipid ves-
icles of the type and composition studied here could provide a way of
screening peptides with high lytic activity and identifying bacteria
which secrete highly cytolytic proteins.
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